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A multicomponent reaction (MCR) between amines, aldehydes, and isocyanides bearing an acidic
R-proton gives easy access to a diverse range of highly substituted 2-imidazolines. The limitations
of the methodology seem to be determined by the reactivity of the isocyanide and by the steric bulk
on the in situ generated imine rather than by the presence of additional functional groups on the
imine. Less reactive isocyanides, for example p-nitrobenzyl isocyanide 25a, react successfully with
amines and aldehydes, using a catalytic amount of silver(I) acetate. Some of the resulting
p-nitrophenyl-substituted 2-imidazolines undergo air oxidation to the corresponding imidazoles.
Differences in reactivity of the employed isocyanides are explained with use of DFT calculations.
Difficult reactions with ketones instead of aldehydes as the oxo-compound in this MCR are promoted
by silver(I) acetate as well.
Introduction
In the past decades, 2-imidazoline derivatives have
attracted considerable interest because of their wide
variety of biological activities. Several 2-imidazolines
have a high affinity for imidazoline binding sites (IBS).1
These IBS are being increasingly studied for their
involvement in hypertension, regulation of blood pres-
sure, insulin secretion control, and numerous human
brain disorders such as depression, neurodegeneration,
and opioid tolerance/dependence.2 Moreover, a series of
highly substituted cis-imidazoline analogues called Nut-
lins (Nutley inhibitors) has been successfully screened
as inhibitors of MDM2, a protein that negatively modu-
lates the transcriptional activity and stability of the p53
tumor suppressor protein.3 Crystal structures show that
the Nutlins mimic the interactions of the p53 peptide
with MDM2 to a high degree. The 2-imidazoline core
essentially acts as a fairly rigid replacement of the helical
backbone of p53. Also, 2-imidazolines have been exam-
ined for their hormonal effects due to estrogen receptor
modulation4 as well as for their interaction with R2-
adrenoceptors.5 Studies have been reported on the pos-
sible application of 2-imidazolines as, among others,
antihyperglycemic,6 antiinflammatory,7 antihyperten-
sive,5,8 and antihypercholesterolemic9 agents. Further-
more, 2-imidazolines are widely used as convenient
building blocks for the synthesis of biologically active
molecules such as azapenams, (bis)dioxocyclams, diaza-
pinones,10 and 2,3-diamino acids.11
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In addition to their pharmaceutical relevance, 2-imi-
dazolines are becoming increasingly important in cataly-
sis. They have been satisfyingly employed as chiral
ligands in asymmetric catalysis.12 More important, how-
ever, is their growing application as precursors for
N-heterocyclic carbene (NHC) ligands.13 These remark-
ably stable carbenes exhibit properties strikingly similar
and even superior to those of the electron-rich organo-
phosphanes PR3.14 Therefore, phosphorus ligands have
often been advantageously replaced by NHCs as ligands
in transition metal catalysis.15 Nitrogen alkylation of 2H-
2-imidazolines and subsequent deprotonation of the
corresponding salts is an established and elegant way to
generate saturated NHCs.16
Evidently, 2-imidazolines are interesting synthetic
targets. Both medicinal chemists and researchers in-
volved in catalysis will benefit from simple and flexible
2-imidazoline syntheses, which facilitate fast and efficient
generation of diverse libraries of these compounds for
high-throughput screening procedures. However, tradi-
tional linear synthetic approaches toward 2-imidazolines
involve multiple steps and are rather limited in scope.17
A powerful alternative strategy for the rapid introduction
of molecular diversity involves multicomponent reactions
(MCRs).18 Recently, we reported a versatile multicom-
ponent synthesis of 2H-2-imidazolines 5 from amines 1,
aldehydes 2, and isocyanides 4 (Scheme 1).17 The MCR
probably involves an aldol-type addition of the isocyanide
4 to the in situ generated imine 3 followed by ring closure
of intermediate A.19 However, a concerted cyclization of
3 and 4 to produce 5 cannot be excluded.
The compatibility of a range of structurally different
aldehydes and amines in this MCR was demonstrated,
but the reaction seems to be critically dependent on the
acidity of the isocyanide R-proton. So far, the method
proved useful to prepare 4-disubstituted 2-imidazolines.
Also, the yield of the MCR decreased notably when the
rather bulky benzhydrylamine was used as amine com-
ponent 1. Finally, ketones were not tested yet as the oxo-
component in the MCR. Here, we wish to report an
extensive scope study addressing the following issues: (i)
the influence of sterically demanding and/or more func-
tionalized amines and aldehydes; (ii) further variation
of the isocyanide component; and (iii) the application of
ketones instead of aldehydes as the oxo-components in
the MCR.
Results and Discussion
Steric factors were believed to cause the disappointing
yields for MCRs with benzhydrylamine and isobutyral-
dehyde as the amine and aldehyde components, respec-
tively. Bulky groups hinder the aldol-type addition of the
isocyanide 4 to the in situ generated imine 3. To
investigate if these factors indeed determine the limita-
tions of the MCR, a series of sterically more and less
demanding amines and aldehydes was tested in combi-
nation with isocyanoacetate 4a (Table 1).
The application of bulky amines such as tert-butyl-
amine, 2,4,6-trimethylaniline, or benzhydrylamine re-
sults in diminished yields of 5 (5hmr, 5ins, and 5jot,
respectively), unless a very small aldehyde like formal-
dehyde is used (5c-e). On the other hand, sterically
demanding aldehydes such as pivaldehyde and mesital-
dehyde react even more sluggishly. Not only do they give
no detectable formation of 2-imidazoline in combination
with the moderately bulky isopropylamine (5l and 5q),
a tert-butyl group on the aldehyde even slows down the
reaction significantly when ammonia is used as the
amine component (5k), although the isolated yield of 5k
was still reasonable after prolonged stirring at room
temperature. Application of mesitaldehyde together with
ammonia proved to be satisfying (5p). It is unlikely that
low yields are due to sluggish imine formation, because
in general, considerable amounts of imine could be
recovered after the reaction. The presence of one or two
moderately bulky groups on the in situ formed imine does
not hinder the aldol-type addition (5b, 5f, and 5g), but
surprisingly, combination of ammonia, paraformalde-
hyde, and 4a furnished only the 2-oxazoline, resulting
from a reaction between the in situ generated formalde-
hyde and isocyanoacetate 4a.20 In conclusion, the results
presented in Table 1 indicate that steric congestion
around the imine carbon indeed influences the aldol-type
addition step of the 2-imidazoline formation (toward the
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proposed intermediate A in Scheme 1). Furthermore, they
suggest that only one sterically demanding group on the
in situ formed imine is allowed.
To synthesize 2-imidazolines susceptible to further
manipulation, amines and aldehydes containing ad-
ditional functional groups were tested in our MCR (Table
2). Although application of an R,â-unsaturated aldehyde
proved successful before,17 the use of acrolein 7 resulted
in an unidentified mixture of polymers (entry 1). On the
other hand, allylamine 9 furnished an imidazoline bear-
ing a terminal alkene substituent suitable for, e.g., olefin
metathesis or rhodium-catalyzed ring closure (entry 2).21
The ease with which unprotected alcohols in both the
amine and the aldehyde component can be accommodated
is illustrated by entries 3-5. Because of insolubility of
the imine derived from amine 18 and aldehyde 16 in
DCM, the synthesis of 2-imidazoline 19 was performed
in methanol.
Many studies are dedicated to the promising abilities
of multivalent ligands and inhibitors for the manipula-
tion of polyvalent interactions between biological enti-
ties.22 It has been established that, in comparison with
their monomeric counterparts, dimeric molecules often
show higher biological activity. Therefore, we decided to
investigate the potential of our MCR to access products
containing multiple 2-imidazoline units connected by
various tethers. Such bis-imidazolines would be valuable
precursors for bidentate NHC ligands for transition metal
catalysis as well. In Schemes 2 and 3, the synthesis of
two different bis-imidazolines is illustrated. Reaction of
hexane-1,6-diamine (20) with isobutyraldehyde (10) (2
equiv) and 9-isocyanofluorene (4b) (2 equiv) efficiently
provides hexane-tethered bis-imidazoline 21. With both
1H and 13C NMR measurements, no distinction between
the two possible diastereomers could be made. Reaction
of isophthalaldehyde (22) with isopropylamine (6) (2
equiv) and 4b (2 equiv) gave bis-imidazoline 23 contain-
ing a somewhat more rigid tether. Again, the diastere-
omeric ratio could not be determined from the NMR data.
Because further variation of the isocyanide component
in the multicomponent synthesis of 2-imidazolines would
significantly increase the versatility of the reaction,
(21) The first example of a rhodium-catalyzed direct C-H insertion
of 4,4-dimethyl-2-imidazoline to 3,3-dimethylbut-1-ene was reported
in: Wiedemann, S. H.; Bergman, R. G.; Ellman, J. A. Org. Lett. 2004,
6, 1685-1687.
(22) Mammen, M.; Choi, S.-K.; Whitesides, G. M. Angew. Chem.,
Int. Ed. 1998, 37, 2754-2794 and references therein.
TABLE 1. The Influence of Sterically Demanding Amine and Aldehyde Substituentsa,b
R1 ) Hc R1 ) i-Pr R1 ) t-Bu R1 ) Mes R1 ) CHPh2
R2 ) Hd 5a, <5%e,f 5b, 70% 5c, 69% 5d, 65% 5e, 82%
R2 ) i-Pr 5f, 76% (68:32) 5g, 74% (75:25) 5h, 21% (anti) 5i, <5%e 5j, 13% (66:34)
R2 ) t-Bu 5k, 56%g (78:22) 5l, <5%e 5m, <5%h 5n, <5%e 5o, <5%e
R2 ) Mes 5p, 67% (anti) 5q, <5%e 5r, 15% (anti) 5s, <5%e 5t, 17% (74:26)
a Isolated yields and diastereomeric ratios are reported, unless stated otherwise. b Structures containing asymmetric carbons represent
racemic compounds. c A solution of 2 N NH3 in MeOH was used. d Paraformaldehyde was used. e In the 1H NMR spectrum of the crude
product, no 2-imidazoline could be observed. f The corresponding 2-oxazoline was isolated in quantitative yield. g Yield after stirring for
3 days. After a reaction time of 18 h, only 20% of 5k could be isolated. h The corresponding 2-oxazoline was isolated in 10% yield.
TABLE 2. Synthesis of 2-Imidazolines with
Functionalized Amines and Aldehydesa
a 9-Isocyanofluorene 4b was used as the isocyanide component.
For structure, see ref 17. b Isolated yields are reported. c Reaction
was performed in methanol. d Yield after flash column chroma-
tography and crystallization.
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additional isocyanides with acidic R-protons were con-
sidered as well. To synthesize 4-monosubstituted 2-imi-
dazolines 24, we explored the use of isocyanides with the
general structure 25 (eq 1).
p-Nitrobenzyl isocyanide (25a) was envisioned as an
isocyanide of type 25 that still contains a fairly acidic
methylene unit. It was synthesized from the correspond-
ing amine 26, which was prepared according to a litera-
ture procedure23 in two steps (overall yield 98%).
The first attempt to allow 25a to react with the in situ
generated imine of isopropylamine (6) and isobutyralde-
hyde (10) did not result in the formation of the desired
product 28 (Table 3, entry 1). Only imine and isocyanide
25a could be isolated. Also performing the reaction at a
higher temperature was unsuccessful (entry 2). Instead
of using even higher temperatures to obtain the 2-imi-
dazoline 28, another method was conceived. Several
studies have been conducted on the increased acidity of
R-protons of isocyanides coordinated to metals.24 Transi-
tion metal catalyzed cycloadditions of various isocyanoac-
etates,25 benzyl isocyanide,26 and allyl isocyanide27 to a
range of electron-poor olefins or aldehydes have been
reported. The cycloaddition to imines, however, required
CdN bond activation by the introduction of a sulfonyl
group on the imine nitrogen.28 In 1999, Grigg et al.
described the efficient silver(I) acetate catalyzed cycload-
dition of methyl isocyanoacetate to Michael acceptors.29
We envisioned silver(I) acetate as a suitable Lewis acid
to activate p-nitrobenzyl isocyanide (25a). Indeed, one-
pot reaction of 25a with 6 and 10 in the presence of only
2 mol % of silver(I) acetate provided 2-imidazoline anti-
28 in 39% yield as a single diastereomer (Table 3, entry
3).
Besides anti-28, another product was isolated in 27%
yield after flash column chromatography.30 This product
was identified as imidazole 29 (Scheme 5). Apparently,
some of the initially formed imidazoline had been oxi-
dized during the reaction or during workup/purification.31
(23) Katayama, S.; Ae, N.; Kodo, T.; Masumoto, S.; Hourai, S.;
Tamamura, C.; Tanaka, H.; Nagata, R. J. Med. Chem. 2003, 46, 691-
701.
(24) For examples see: (a) Fehlhammer, W. P.; Bartel, K.; Petri,
W. J. Organomet. Chem. 1975, 87, C34-C36. (b) Fehlhammer, W. P.;
Zinner, G.; Bakola-Christianopoulou, M. J. Organomet. Chem. 1987,
331, 193-205.
(25) For examples see: Soloshonok, V. A.; Kacharov, A. D.; Avilov,
D. V.; Ishikawa, K.; Nagashima, N.; Hayashi, T. J. Org. Chem. 1997,
62, 3470-3479 and references therein.
(26) Saegusa, T.; Ito, Y.; Kinoshita, H.; Tomita, S. J. Org. Chem.
1971, 36, 3316-3323.
(27) Saegusa, T.; Murase, I.; Ito, Y. Bull. Chem. Soc. Jpn. 1972, 45,
830-833.
(28) Dai, L.-X.; Lin, Y.-R.; Hou, X.-L.; Zhou, Y.-G. Pure Appl. Chem.
1999, 71, 1033-1040 and references therein.
(29) Grigg, R.; Lansdell, M. I.; Thornton-Pett, M. Tetrahedron 1999,
55, 2025-2044.
(30) A second byproduct, isolated in only 7%, was characterized as
the oxazoline formed by reaction of 25a and 10.
(31) For a recent example of the air oxidation of imidazolines to
imidazoles see: Illgen, K.; Nerdinger, S.; Behnke, D.; Friedrich, C. Org.
Lett. 2005, 7, 39-42.
SCHEME 2. A Bis-imidazoline from
Hexane-1,6-diamine
SCHEME 3. A Bis-imidazoline from
Isophthalaldehyde
TABLE 3. Synthesis of 4-Monosubstituted 2-Imidazoline
28
entry T, °C catalyst yield,a %
1 20 none 0b
2 60 none 0b
3 20 AgOAcc 39 (anti)d,e
a Isolated yields are reported. b Only imine and isocyanide 25a
were recovered. c 2 mol % of AgOAc was used. d Relative stereo-
chemistry was determined from the 1H NMR coupling constants
of H-4 and H-5. e Also the corresponding imidazole 29 was isolated
in 27% yield.
SCHEME 4. Synthesis of p-Nitrobenzyl Isocyanide
25aa
a Reagents and conditions: (a) acetic formic anhydride, DCM,
0 °C to rt, 1 h; (b) POCl3, Et3N, THF, -78 to 0 °C, 1 h.
SCHEME 5. Air Oxidation of
p-Nitrophenyl-Substituted Imidazolines syn-28 and
anti-28
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Because complete diastereoselectivity had never been
observed before in our MCR, we reasoned that 29 should
be formed from syn-28. To test this hypothesis, and to
examine the factors causing the oxidation, both the MCR
and subsequent workup were performed under exclusion
of oxygen. Indeed, in the crude product a mixture of anti-
28 and syn-28 could be observed in a ratio of 58:42
according to 1H NMR. When this crude mixture was
subjected to air, syn-28 was rapidly oxidized to 29, even
in the absence of light. Also anti-28 is not infinitely air-
stable. After storing a purified sample for half a year
under air, it contained about 75% of the oxidized product
29. In conclusion, 29 is a product of the air oxidation of
syn-28 (fast) and/or anti-28 (very slow) (Scheme 5). For
this oxidation, neither silver(I) catalyst nor light is
needed.
The proposed mechanism for the silver(I) catalyzed
MCR with p-nitrobenzyl isocyanide (25a) is depicted in
Scheme 6. It is believed that the activated isocyanide 30
is deprotonated by either the acetate anion or a trace of
amine present in the reaction mixture (acting as base B
after in situ imine formation). Then, the imine 31 is
attacked by the deprotonated complex 32 to give aldol
adduct 33. Ring closure of the secondary amine followed
by exchange of the silver(I) cation by a proton would
provide the 2-imidazoline 35. The formation of 34 from
31 and 32 may proceed via either a concerted cycload-
dition or a stepwise mechanism. An alternative pathway
would involve the aldol-type addition to an iminium ion
intermediate.
Variation of the amine and aldehyde substituents gave
two more 4-nitrophenyl-substituted 2-imidazolines 36
and 37 in reasonable to good yields (Chart 1). According
to NOESY measurements, for 2-imidazoline 36, the syn-
diastereomer was formed in excess. In the crude product
37, both diastereomers anti-37 and syn-37 could be
detected in a 62:38 ratio. However, after flash column
chromatography only anti-37 and the corresponding
imidazole were isolated. Both diastereomers of 36 ap-
peared to be much more air-stable. Nevertheless, after
storing the mixture for months under air, both diaster-
eomers were oxidized to the imidazole.
The air oxidation of 2-imidazolines could proceed via
a radical stabilized by the p-nitrophenyl group. For the
oxidation of both diatereomers, similar radical intermedi-
ates are expected. For the syn-diastereomers, the two
substituents at C-4 and C-5 move away from each other
during this radical formation (this reduces the steric
repulsion), whereas for the anti-diastereomers, these
groups move toward each other (this increases the steric
repulsion). Formation of this radical intermediate should
be faster from the syn-diastereomers than for the anti-
diastereomers. This is supported by density functional
theory (DFT)32 calculations that show the anti-imidazo-
lines to be more stable than their syn counterparts by
2-5 kcal/mol (Table 4).
Encouraged by the good results in the silver(I) cata-
lyzed reactions of 25a, allyl isocyanide 25b was tested
to synthesize more 2-imidazolines of type 24. Combina-
tion of p-methoxybenzylamine (15), p-anisaldehyde (38),
and 25b without catalyst did not result in any imidazo-
line formation (Scheme 7). Addition of silver(I) acetate
to the reaction mixture did not promote the cycloaddition.
In both cases, only the imine derived from 15 and 38 was
isolated after evaporation of the solvent and unreacted
25b. Apparently, the reactivity of activated allyl isocya-
nide toward imines is considerably lower compared to
that of 25a.
To rationalize the differences in reactivity of the
various isocyanides in our MCR, DFT (BP86/TZ2P)
calculations proved helpful. The proposed mechanism for
the aldol-type addition probably involves deprotonation
of the isocyanide followed by attack of the anion to the
(protonated) imine. Three aspects are important for
understanding the reactivity: the proton affinity (PA) of
the isocyanide (which correlates to the acidity), the orbital
(32) Koch, W.; Holthausen, M. C. A Chemist’s Guide to Density
Functional Theory; Wiley-VCH: Weinheim, Germany, 2000.
SCHEME 6. Proposed Mechanism for the
Silver(I)-Catalyzed Cycloaddition of 25a to Imines
31
CHART 1. 4-Nitrophenyl-Substituted
2-Imidazolines
TABLE 4. Calculated Energy Differences between syn-
and anti-Imidazolines
entry compd ¢E(syn)-(anti),a kcal/mol
1 28 4.0
2 36 2.0
3 37 4.7
a BP86/TZP.
SCHEME 7. Attempts toward the Synthesis of
4-Vinyl-Substituted 2-Imidazoline 39a
a Reagents and conditions: (a) Na2SO4, DCM, rt, 18 h; (b)
Na2SO4, AgOAc (2 mol %), DCM, rt, 18 h.
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energy of the highest occupied molecular orbital (HOMO)
of its carbanion, and the contribution of carbanion
orbitals in the HOMO. The PA of a molecule BH is
defined as the system’s enthalpy change for the reaction
BH f B- + H+, e.g., a smaller PA corresponds to a larger
concentration of the B- anion. The difference in energy
between the HOMO of the attacking deprotonated com-
plex and the lowest unoccupied orbital (LUMO) of the
imine (or the iminium ion) determines the interaction
between the two. Thus, the reactivity is governed by the
[B-], the HOMO-LUMO gap, and the contribution of
carbanion orbitals in the HOMO.
The computational setup for calculating PAs was
validated against a series of organic and inorganic bases,
for which experimental data are available.33 It was shown
that DFT gives both qualitatively and quantitatively good
results for proton affinities.34 Solvent effects (DCM) are
properly taken into account by the COSMO model.35 DFT
calculations were performed for five different isocya-
nides: 4a, 4b, 25a, 25b, and methyl isocyanoacetate 4c,
which is also known to undergo cycloadditions with
imines (Table 5).19a
The two isocyanides that display the highest reactivity
in our MCR, 4a and 4b (entries 1 and 2), have similar
values for the PA (ca. 181 kcal/mol),36 HOMO orbital
energy (ca. -3.7 eV), and contribution of carbanion (pz)
orbital in the HOMO (ca. 30%). These values can be taken
as reference values for the reactivity of isocyanides in
our MCR. Methyl isocyanoacetate 4c (entry 3) has a
larger contribution of carbanion orbitals in the HOMO,
in fact the largest of all isocyanides we studied, and a
HOMO orbital energy that is comparable to that of 4b
(entry 2). However, its proton affinity is almost 10 kcal/
mol larger than that of 4a and 4b, which would result in
a lower carbanion concentration and hence a lower
reactivity. This is consistent with our previously reported
experiments.17
Although its PA and contribution of the carbanion
orbital in the HOMO are similar to those of 4a (entry 1),
p-nitrobenzyl isocyanide (25a) (entry 4) does not react
with imines in the absence of silver(I). Its nonreactivity
is ascribed to its HOMO being 0.4 eV lower in energy
than that of 4a. The activation by silver(I) has mainly
an effect on the PA of 25a, which is reduced by almost
12 kcal/mol (entry 5). Consequently, the concentration
of carbanion increases significantly, which apparently
compensates for the still rather poor HOMO and causes
the reaction to proceed after activation. Based on the
HOMO orbital energy and the contribution of the car-
banion pz-orbital in it, allyl isocyanide (25b) should be
able to react with imines, were it not for its very high
PA, which is, in fact, the highest of the series. Prelimi-
nary results suggest that the PA of allyl groups may even
be underestimated by our computational setup by up to
5 kcal/mol.34 This makes it unlikely that any carbanions
are present (entry 6). After activation by silver(I), the PA
becomes comparable to that of 4a or 4b, which should
be sufficient for reaction, but both the HOMO orbital
energy and the contribution of the carbanion pz-orbital
in the HOMO decrease dramatically, by 1.3 eV and from
37% to 26%, respectively (entry 7). As a result, the
carbanions will not be reactive toward imines. Further-
more, it was found that, for the anion of 25b, not the
isocyano group but the allyl group is the energetically
favored coordination site for silver(I) (a difference of ca.
5 kcal/mol, see the Supporting Information for details).
This thermodynamically more stable complex has a
HOMO energy of -5.10 eV and a contribution of the
carbanion pz-orbital of only 22.9%. Therefore, nucleophilic
attack would be even more hampered.
Instead of aldehydes, ketones also could be imagined
as the oxo-components in the multicomponent synthesis
of 2-imidazolines. However, both steric and electronic
effects might decrease the reactivity of the in situ formed
ketimines. The first attempts to apply cyclohexanone 40
in the MCR gave disappointing results (Table 6). With
either 9-isocyanofluorene (4b) or p-nitrobenzyl isocyanide
(25a), no 2-imidazoline was formed at all (entries 1 and
3). Employing isocyanoacetate 4a as the isocyanide
component gave the expected 5-disubstituted product,
(33) Bickelhaupt, F. M.; Buisman, G. J. H.; de Koning, L. J.;
Nibbering, N. M. M.; Baerends, E. J. J. Am. Chem. Soc. 1995, 117,
9889-9899.
(34) Swart, M.; Bickelhaupt, F. M. Unpublished results.
(35) (a) Klamt, A.; Schu¨u¨rmann, G. J. Chem. Soc., Perkin Trans. 2
1993, 799-805. (b) Pye, C. C.; Ziegler, T. Theor. Chem. Acc. 1999, 101,
396-408.
(36) The measured pKa of 4b in DMSO (25 °C) is 12.3, see: Bordwell,
F. G. Acc. Chem. Res. 1988, 21, 456-463.
TABLE 5. Computed Proton Affinities (kcal/mol) of
Isocyanides and Orbital Energies of the HOMOs (eV) and
Contributions of pz-Orbitals in HOMOs (%) of Their
Anionsa,b
entry isocyanide
Ag+
coordinated
PA,
kcal/mol
HOMO,a
eV % pz(Canion)
1 4a no 181.4 -3.63 27.4
2 4b no 180.3 -3.87 31.5
3 4c no 190.3 -3.91 47.6
4 25a no 181.9 -4.01 27.9
5 25a yes 170.2 -4.63 27.3
6 25b no 200.8 -3.01 36.9
7 25b yes 179.5 -4.31 26.1
a BP86/TZ2P. b In all calculations, DCM was taken as the
solvent.
TABLE 6. MCRs with Cyclohexanone 40
entry isocyanide catalyst yield, %
1 4b none 0a
2 4a none 7
3 25a none 0a
4 4b AgOAcb 20
5 4a AgOAcb 55
6 25a AgOAcb 77
a Only imine and isocyanide were isolated. b 2 mol % of AgOAc
was used.
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albeit in only 7% yield (entry 2). Addition of a catalytic
amount of silver(I) acetate appeared to be sufficient to
activate the isocyanides to such an extent that reaction
with the less electrophilic ketimines (as compared to the
similar aldimines) is accelerated, which resulted in
significantly increased yields (entries 4-6). The some-
what low yield for 42 is probably the result of steric
factors. This is supported by experiments that combine
acetone, benzylamine, and isocyanides (4a, 4b, and 25a)
in the silver(I) catalyzed MCR, which furnished 2-imi-
dazolines 45-47 (Chart 2). Even with 9-isocyanofluorene
(4b) a good yield was obtained now.
When 3-(chloromethyl)cyclobutanone (48)37 was ap-
plied, no additional catalyst was needed to perform the
MCR (Scheme 8). Reaction of 48, benzylamine (41), and
9-isocyanofluorene (4b) provided 2-imidazolines 49a and
49b, which contain a chloromethyl unit suitable for
further derivatization, as a mixture of isomers. The
identity of the trans-isomer 49a was established by NOE
measurements. Also isocyanoacetate 4a gave good results
when reacted with 48 and 41 (Scheme 9).38 Again, NOE
measurements were used for the identification of the
trans-isomer 50a. The relatively high reactivity of imines
derived from cyclobutanone compared to the other
ketimines can be accounted for by the release of ring
strain, going from an sp2 ring carbon to an sp3 ring
carbon.
Conclusions and Outlook
The scope of the multicomponent synthesis of 2H-2-
imidazolines from isocyanides bearing acidic R-protons
and in situ generated imines has been studied exten-
sively. Three different isocyanides were used in combina-
tion with aldehydes and amines containing a variety of
simple and functionalized side chains. The most impor-
tant limitations are the steric bulk of the imine substit-
uents and the reactivity of the isocyanide. Both the ease
with which the isocyanide is deprotonated and the
reactivity of the anion are important. Silver(I) catalysis
appeared to be an excellent method to promote both
difficult aldol-type additions to ketimines and reactions
with p-nitrobenzyl isocyanide. The resulting p-nitrophe-
nyl-substituted 2-imidazolines are relatively unstable to
air. Both diastereomers are oxidized under air exposure
(although with different rates) to the corresponding
imidazoles. This MCR/oxidation procedure could be de-
veloped toward a useful and flexible imidazole synthesis
additional to Sisko’s methodology.39 For the application
of allyl isocyanide in the MCR, probably stronger activa-
tors for either the isocyanide or the imine are required.
Currently, we are investigating the activation of iso-
cyanides with transition metals complexed to chiral
ligands in order to achieve stereoselective aldol addition
to in situ formed imines. Finally, different mono- and
dimeric imidazolines are being used as precursors for
N-heterocyclic carbenes containing two different C-back-
bone substituents.
Theory
DFT (BP86) calculations were performed with the Amster-
dam Density Functional (ADF) program.40 The MOs were
expanded in large uncontracted sets of Slater-type orbitals,41
which are of triple-œ quality, augmented by one (TZP: 3d on
C, N, O; 2p on H) or two sets of polarization functions (TZ2P:
3d and 4f on C, N, O; 2p and 3d on H; 5p and 4f on Ag); the 1s
core shell of carbon, nitrogen, oxygen and the 1s-3d core shells
of silver were treated by the frozen core (FC) approximation.40b
An auxiliary set of s, p, d, f, and g STOs was used to fit the
molecular density and to represent the Coulomb and exchange
potentials accurately in each SCF cycle. For the silver-
containing systems, (scalar) relativistic effects were taken into
account with use of the zeroth-order regular approximation
(ZORA).40b,42
Energies and gradients were calculated by using the local
density approximation (LDA; Slater exchange and VWN
correlation)43 with nonlocal corrections due to Becke44 (ex-
change) and Perdew45 (correlation) added self-consistently.
This xc-functional is one of the three best DFT functionals for
the accuracy of geometries,46 with an estimated unsigned error
(37) (a) Stevens, C. V.; de Kimpe, N. J. Org. Chem. 1996, 61, 2174-
2178. (b) Rammeloo, T.; Stevens, C. V.; de Kimpe, N. J. Org. Chem.
2002, 67, 6509-6513.
(38) Application of the almost pure imine from 48 and 41 (prepared
with TiCl4, see ref 36b) resulted in even higher yields for 50a (42%)
and 50b (33%).
(39) Sisko, J.; Kassick, A. J.; Mellinger, M.; Filan, J. J.; Allen, A.;
Olsen, M. A. J. Org. Chem. 2000, 65, 1516-1524.
(40) (a) te Velde, G.; Bickelhaupt, F. M.; Baerends, E. J.; Fonseca
Guerra, C.; van Gisbergen, S. J. A.; Snijders, J. G.; Ziegler, T. J.
Comput. Chem. 2001, 22, 931-967. (b) Fonseca Guerra, C.; Snijders,
J. G.; te Velde, G.; Baerends, E. J. Theor. Chem. Acc. 1998, 99, 391-
403. (c) ADF 2004.01; SCM, Theoretical Chemistry, Vrije Universiteit,
Amsterdam, The Netherlands, http://www.scm.com.
(41) van Lenthe, E.; Baerends, E. J. J. Comput. Chem. 2003, 24,
1142-1156.
(42) van Lenthe, E.; Baerends, E. J.; Snijders, J. G. J. Chem. Phys.
1993, 99, 4597-4610.
(43) Vosko, S. H.; Wilk, L.; Nusair, M. Can. J. Phys. 1980, 58, 1200-
1211.
(44) Becke, A. D. Phys. Rev. A 1988, 38, 3098-3100.
(45) Perdew, J. P. Phys. Rev. B 1986, 33, 8822-8824. Erratum:
Perdew, J. P. Phys. Rev. B 1986, 34, 7406-7406.
CHART 2. 2-Imidazolines Synthesized from
Acetone with Silver(I) Acetate as Catalyst
SCHEME 8. Synthesis of 49a and 49b
SCHEME 9. Synthesis of 50a and 50b
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of 0.009 Å in combination with the TZ2P basis set. Geometries
were optimized by using analytical gradient techniques until
the maximum gradient component was less than 1.0  10-4
atomic units. Vibrational frequencies were obtained through
numerical differentiation of the analytical gradients.40b
Experimental Section
For general experimental methods, see the Supporting
Information. Experimental details and characterization data
for compounds 5g and 5j have been reported elsewhere.17
General Procedure I for the Synthesis of 2-Imidazo-
lines. Reactions were carried out at a concentration of 1 M of
amine, 1 M of aldehyde (or ketone), and 0.5 M of isocyanide
in dry CH2Cl2, unless noted otherwise. Na2SO4 and the
aldehyde were added, at room temperature, to a stirred
solution of the amine. After the mixture was stirred for 2 h,
the isocyanide was added and the reaction mixture was stirred
at room temperature for an additional 18 h. The reaction
mixture was then filtered and concentrated in vacuo. The
crude product was purified by flash column chromatography
(PE:EtOAc:Et3N ) 2:1:0.01, gradient, unless stated otherwise).
Methyl 4-Phenyl-4,5-dihydro-1H-imidazole-4-carboxy-
late (5a). According to General Procedure I, reaction between
NH3 (2 M in MeOH, 2.3 mL, 4.6 mmol), p-formaldehyde (60
mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol), followed by flash
column chromatography (EtOAc:MeOH:Et3N ) 1:0:0.01, gra-
dient), did not afford 5a, but the corresponding 2-oxazoline
(235 mg, quant) as a yellow oil. 1H NMR (250 MHz, CDCl3) ä
(ppm) 7.42-7.28 (m, 5H), 7.08 (s, 1H), 5.21 (d, J ) 8.9 Hz,
1H), 4.28 (d, J ) 8.9 Hz, 1H), 3.77 (s, 3H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 171.4 (C), 161.0 (CH), 136.2 (C), 128.8 (2 
CH), 128.5 (CH), 126.0 (2  CH), 67.8 (C), 64.7 (CH2), 53.5
(CH3); IR (neat) 2956 (s), 1757 (s), 1257 (s), 1214 (s) cm-1; MS
(EI, 70 eV) m/z (%) )205 (0.5) [M]+, 187 (100), 145 (68).
Methyl 1-Isopropyl-4-phenyl-4,5-dihydro-1H-imidazole-
4-carboxylate (5b). According to General Procedure I, reac-
tion between isopropylamine (118 mg, 2.0 mmol), p-formalde-
hyde (60 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol), followed
by flash column chromatography (EtOAc:MeOH:Et3N ) 1:0:
0.01, gradient), afforded 5b (173 mg, 70%) as a yellow oil. 1H
NMR (250 MHz, CDCl3) ä (ppm) 7.40-7.19 (m, 5H), 6.98 (s,
1H), 4.27 (d, J ) 9.6 Hz, 1H), 3.63 (s, 3H), 3.53-3.42 (m, 1H),
3.27 (d, J ) 9.6 Hz, 1H), 1.15 (d, J ) 6.6 Hz, 3H), 1.11 (d, J )
6.6 Hz, 3H); 13C NMR (63 MHz, CDCl3) ä (ppm) 173.9 (C), 154.8
(CH), 143.1 (C), 128.4 (2  CH), 127.3 (CH), 125.4 (2  CH),
79.1 (C), 54.6 (CH2), 52.8 (CH3), 47.6 (CH), 21.14 (CH3), 21.09
(CH3); IR (neat) 2970 (s), 1726 (s), 1593 (s), 1254 (s), 1214 (s)
cm-1; HRMS (EI, 70 eV) calcd for C14H18N2O2 (M+) 246.1368,
found 246.1392.
Methyl 1-tert-Butyl-4-phenyl-4,5-dihydro-1H-imidazole-
4-carboxylate (5c). According to General Procedure I, reac-
tion between tert-butylamine (88 mg, 1.2 mmol), p-formalde-
hyde (36 mg, 1.2 mmol), and 4a (98 mg, 0.56 mmol), followed
by flash column chromatography, afforded 5c (100 mg, 69%)
as a yellow oil. 1H NMR (250 MHz, CDCl3) ä (ppm) 7.39-7.35
(m, 2H), 7.29-7.18 (m, 3H), 7.10 (s, 1H), 4.31 (d, J ) 9.7 Hz,
1H), 3.62 (s, 3H), 3.30 (d, J ) 9.7 Hz, 1H), 1.18 (s, 9H); 13C
NMR (101 MHz, CDCl3) ä (ppm) 174.1 (C), 153.6 (CH), 143.4
(C), 128.5 (2  CH), 127.4 (CH), 125.6 (2  CH), 79.2 (C), 54.3
(CH2), 52.9 (CH3), 52.5 (C), 29.1 (3  CH3); IR (neat) 2972 (s),
1726 (s), 1592 (s), 1258 (s), 1236 (s), 1201 (s); HRMS (EI, 70
eV) calcd for C15H20N2O2 (M+) 286.1893, found 286.1890.
Methyl 1-Mesityl-4-phenyl-4,5-dihydro-1H-imidazole-
4-carboxylate (5d). According to General Procedure I, reac-
tion between 2,4,6-trimethylaniline (270 mg, 2.0 mmol),
p-formaldehyde (60 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol),
followed by flash column chromatography, afforded 5d (209
mg, 65%) as a yellow oil. 1H NMR (250 MHz, CDCl3) ä (ppm)
7.76-7.50 (m, 6H), 7.15-7.11 (m, 2H), 4.94 (d, J ) 9.8 Hz,
1H), 4.01 (s, 3H), 3.81 (d, J ) 9.8 Hz, 1H), 2.52 (s, 3H), 2.50-
2.29 (br s, 6H); 13C NMR (63 MHz, CDCl3) ä (ppm) 173.7 (C),
155.7 (CH), 143.2 (2  C), 137.8 (2  C), 133.3 (C), 129.3 (2 
CH), 128.6 (2  CH), 127.5 (CH), 125.5 (2  CH), 80.4 (C),
58.7 (CH2), 53.0 (CH3), 20.8 (CH3), 17.8 (2  CH3); IR (neat)
2951 (m), 2923 (m), 1729 (s), 1600 (s), 1576 (s), 1488 (s), 1263
(s), 1217 (s) cm-1; HRMS (EI, 70 eV) calcd for C20H22N2O2 (M+)
322.1681, found 322.1672.
Methyl 1-Benzhydryl-4-phenyl-4,5-dihydro-1H-imida-
zole-4-carboxylate (5e). According to General Procedure I,
reaction between benzhydrylamine (366 mg, 2.0 mmol), p-
formaldehyde (60 mg, 2.0 mmol), and 4a (196 mg, 1.12 mmol),
followed by flash column chromatography, afforded 5e (340
mg, 82%) as a yellow oil. 1H NMR (250 MHz, CDCl3) ä (ppm)
7.34-7.30 (m, 2H), 7.25-7.08 (m, 12H), 7.00-6.85 (m, 1H),
6.82 (s, 1H), 5.32 (s, 1H), 4.24 (d, J ) 9.8 Hz, 1H), 3.59 (s,
3H), 3.19 (d, J ) 9.8 Hz, 1H); 13C NMR (63 MHz, CDCl3) ä
(ppm) 174.0 (C), 156.4 (CH), 142.8 (C), 139.8 (C), 139.8 (C),
129.3 (2  CH), 129.0 (2  CH), 128.6 (CH), 128.44 (CH),
128.40 (CH), 128.36 (2  CH), 128.3 (2  CH), 128.0 (CH),
127.9 (CH), 126.0 (2  CH), 80.3 (C), 66.4 (CH), 58.6 (CH2),
53.4 (CH3); IR (KBr) 3025 (m), 1721 (s), 1595 (m), 1258 (s),
706 (s) cm-1; HRMS (EI, 70 eV) calcd for C24H22N2O2 (M+)
370.1681, found 370.1691.
Methyl 5-Isopropyl-4-phenyl-4,5-dihydro-1H-imidazole-
4-carboxylate (5f). According to General Procedure I, reaction
between NH3 (2 M in MeOH, 2.3 mL, 4.6 mmol), isobutyral-
dehyde (154 mg, 2.1 mmol), and 4a (192 mg, 1.1 mmol),
followed by flash column chromatography, afforded 5f (206 mg,
76%) as a 68:32 mixture of diastereomers as a yellow oil. 1H
NMR (250 MHz, CDCl3) ä (ppm) 7.60-7.46 (m, 2H), 7.45-
7.33 (m, 2H), 7.30-7.10 (m, 4H + 4H), 6.2 (br s, 1H + 1H),
4.53 (d, J ) 3.2 Hz, 1H), 4.09 (d, J ) 2.2 Hz, 1H), 3.64 (s, 3H),
3.62 (s, 3H), 2.45-2.35 (m, 1H), 1.55-1.40 (m, 1H), 1.01 (d, J
) 6.9 Hz, 3H), 0.84 (d, J ) 6.9 Hz, 3H), 0.71 (d, J ) 6.6 Hz,
3H), 0.35 (d, J ) 6.6 Hz, 3H); 13C NMR (63 MHz, CDCl3) ä
(ppm) 175.1 (C), 172.8 (C), 154.1 (CH), 153.3 (CH), 144.1 (C),
136.9 (C), 128.7 (CH), 128.4 (2  CH), 128.1 (CH), 128.0 (CH),
127.5 (2  CH), 126.3 (CH), 78.7 (C), 78.6 (CH), 76.6 (C), 71.7
(CH), 53.3 (CH3), 52.9 (CH3), 29.6 (CH), 29.1 (CH), 22.0 (CH3),
21.8 (CH3), 16.1 (CH3), 16.0 (CH3); IR (KBr) 3136 (m), 2938
(m), 1728 (s), 1221 (s) cm-1; HRMS (EI, 70 eV) calcd for
C14H18N2O2 (M+) 246.1368, found 246.1352.
anti-Methyl 1-tert-Butyl-5-isopropyl-4-phenyl-4,5-di-
hydro-1H-imidazole-4-carboxylate (5h). According to Gen-
eral Procedure I, reaction between tert-butylamine (146 mg,
2.0 mmol), isobutyraldehyde (144 mg, 2.0 mmol), and 4a (190
mg, 1.09 mmol), followed by flash column chromatography,
afforded anti-5h (59 mg, 21%) as a sticky yellow solid. 1H NMR
(250 MHz, CDCl3) ä (ppm) 7.56-7.44 (m, 2H), 7.31-7.17 (m,
4H), 4.50 (d, J ) 2.1 Hz, 1H), 4.48 (s, 3H), 1.58-1.49 (m, 1H),
1.27 (s, 9H), 0.74 (d, J ) 7.2 Hz, 3H), 0.40 (d, J ) 6.9 Hz, 3H);
13C NMR (63 MHz, CDCl3) ä (ppm) 175.2 (C), 155.3 (CH), 137.5
(C), 128.2 (2  CH), 127.9 (2  CH), 127.5 (CH), 83.8 (C), 66.7
(CH), 53.4 (C), 52.7 (CH3), 30.7 (3  CH3), 29.7 (CH), 20.0
(CH3), 17.0 (CH3); IR (neat) 2956 (m), 2914 (m), 2850 (m), 1745
(s), 1667 (s), 1217 (s) cm-1; HRMS (EI, 70 eV) calcd for
C18H26N2O2 (M+) 302.1994, found 302.1998.
Methyl 5-tert-Butyl-4-phenyl-4,5-dihydro-1H-imidazole-
4-carboxylate (5k). According to General Procedure I, reac-
tion between NH3 (2 M in MeOH, 2.0 mL, 4.0 mmol),
pivaldehyde (172 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol),
followed by flash column chromatography, afforded 5k (146
mg, 56%) as a 78:22 mixture of diastereomers as a white solid.
1H NMR (250 MHz, CDCl3) ä (ppm) 7.61-7.56 (m, 2H), 7.49-
7.36 (m, 2H), 7.30-7.16 (m, 4H + 4H), 4.43 (d, J ) 0.9 Hz,
1H), 4.02 (s, 1H), 3.67 (s, 3H), 3.65 (s, 3H), 0.99 (s, 9H), 0.60
(s, 9H); 13C NMR (63 MHz, CDCl3) ä (ppm) 174.8 (C), 172.7
(C), 153.1 (CH), 151.9 (CH), 144.3 (C), 136.3 (C), 128.3 (2 
CH), 128.00 (2  CH), 127.97 (2  CH), 127.8 (2  CH), 127.4
(CH), 126.8 (CH), 84.1 (CH), 78.5 (C), 74.9 (CH), 52.9 (CH3),
52.5 (CH3), 34.8 (C), 34.5 (C), 27.2 (3  CH3), 27.1 (3  CH3)(46) Swart, M.; Snijders, J. G. Theor. Chem. Acc. 2003, 110, 34-41.
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(one-quarternary C of minor diastereomer remained undetect-
able); IR (neat) 3186 (s, br), 2954 (s), 1732 (s), 1597 (s), 1254
(s) cm-1; HRMS (EI, 70 eV) calcd for C15H20N2O2 (M+)
260.1525, found 260.1523.
Methyl 1,5-Di-tert-butyl-4-phenyl-4,5-dihydro-1H-imi-
dazole-4-carboxylate (5m). According to General Procedure
I, reaction between tert-butylamine (146 mg, 2.0 mmol),
pivaldehyde (172 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol),
followed by flash column chromatography, did not afford 5m,
but the corresponding 2-oxazoline (26 mg, 10%) as a single
diastereomer (anti) as a yellow oil. 1H NMR (250 MHz, CDCl3)
ä (ppm) 7.83 (d, J ) 7.2 Hz, 2H), 7.44-7.37 (m, 3H), 7.30-
7.25 (m, 1H), 4.38 (s, 1H), 4.07 (s, 3H), 1.06 (s, 9H); 13C NMR
(63 MHz, CDCl3) ä (ppm) 154.4 (C), 131.1 (C), 129.1 (CH), 128.5
(2  CH), 126.5 (CH), 125.0 (2  CH), 75.8 (CH), 60.4 (C), 60.1
(CH3), 36.0 (C), 25.3 (CH3); IR (neat) 2957 (s), 1741 (s), 1713
(s), 1250 (s), 1079 (s) cm-1; HRMS (EI, 70 eV) calcd for C15H19-
NO3 (M+) 261.1365, found 261.1383.
anti-Methyl 5-Mesityl-4-phenyl-4,5-dihydro-1H-imida-
zole-4-carboxylate (5p). According to General Procedure I,
reaction between NH3 (2 M in MeOH, 2.0 mL, 4.0 mmol),
mesitaldehyde (296 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol),
followed by precipitation from Et2O and PE, afforded anti-5p
(216 mg, 67%) as a white solid. Mp 222-225 °C; 1H NMR (250
MHz, CDCl3) ä (ppm) 7.18-7.09 (m, 3H), 6.98-6.93 (m, 3H),
6.71 (s, 1H), 6.35 (s, 1H), 6.34 (s, 1H), 3.62 (s, 3H), 2.58 (s,
3H), 2.05 (s, 3H), 1.65 (s, 3H); 13C NMR (63 MHz, CDCl3) ä
(ppm) 175.1 (C), 152.3 (CH), 138.4 (C), 137.8 (C), 137.7 (C),
137.0 (C), 131.5 (C), 130.8 (CH), 129.0 (CH), 127.0 (2  CH),
126.9 (CH), 126.8 (2  CH), 81.0 (C)*, 64.5 (CH)*, 53.2 (CH3),
21.4 (CH3), 20.6 (CH3), 20.3 (CH3), The signals labeled with
an asterisk could only be found using gs-HMBC and gs-HMQC
measurements (for the spectra, see the Supporting Informa-
tion); IR (neat) 3056 (s, br), 2949 (s), 2916 (s), 2853 (m), 1732
(s), 1597 (s), 1447 (s), 1232 (s) cm-1; HRMS (EI, 70 eV) calcd
for C20H22N2O2 (M+) 322.1681, found 322.1666.
anti-Methyl 1-tert-Butyl-5-mesityl-4-phenyl-4,5-dihy-
dro-1H-imidazole-4-carboxylate (5r). According to General
Procedure I, reaction between tert-butylamine (146 mg, 2.0
mmol), mesitaldehyde (296 mg, 2.0 mmol), and 4a (175 mg,
1.0 mmol), followed by flash column chromatography, afforded
anti-5r (58 mg, 15%) as a single diastereomer as a sticky white
solid. 1H NMR (250 MHz, CDCl3) ä (ppm) 7.27 (s, 1H), 7.15
(d, J ) 5.9 Hz, 2H), 7.01-6.95 (m, 3H), 6.69 (s, 1H), 6.32 (s,
1H), 6.24 (br s, 1H), 3.66 (s, 3H), 2.63 (s, 3H), 2.08 (s, 3H),
1.80 (s, 3H), 1.18 (s, 9H); 13C NMR (63 MHz, CDCl3) ä (ppm)
175.0 (C), 153.9 (CH), 138.3 (C), 138.0 (C), 136.3 (C), 136.2
(C), 133.6 (C), 130.7 (CH), 128.9 (CH), 126.7 (2  CH), 126.5
(CH), 125.7 (2  CH), 85.5 (C), 61.4 (CH), 54.2 (C), 53.1 (CH3),
29.2 (3  CH3), 21.3 (CH3), 20.8 (CH3), 20.6 (CH3); IR (neat)
2974 (s), 1723 (s), 1597 (s), 1237 (s), 1212 (s), 1197 (s) cm-1;
HRMS (EI, 70 eV) calcd for C24H30N2O2 (M+) 378.2307, found
378.2319.
Methyl 1-Benzhydryl-5-mesityl-4-phenyl-4,5-dihydro-
1H-imidazole-4-carboxylate (5t). According to General
Procedure I, reaction between benzhydrylamine (366 mg, 2.0
mmol), mesitaldehyde (296 mg, 2.0 mmol), and isocyanoacetate
4a (180 mg, 1.03 mmol), followed by flash column chromatog-
raphy, afforded 5t (84 mg, 17%) as a 74:26 mixture of
diastereomers as a yellow oil. 1H NMR (400 MHz, CDCl3) ä
(ppm) 7.65-7.63 (m, 2H), 7.42-6.94 (m, 15H + 13H), 6.90 (s,
1H), 6.83 (s, 1H), 6.81 (s, 1H), 6.74 (s, 1H), 6.66 (s, 1H), 6.48
(s, 1H), 6.20 (s, 1H), 5.33 (s, 1H), 4.99 (s, 1H), 4.94 (s, 1H),
3.67 (s, 3H), 3.33 (s, 3H), 2.28 (s, 3H), 2.27 (s, 3H), 2.14 (s,
3H), 1.92 (s, 3H), 1.73 (s, 3H), 1.71 (s, 3H); 13C NMR (101 MHz,
CDCl3) ä (ppm) 174.9 (C), 171.5 (C), 153.1 (CH), 152.9 (CH),
144.4 (C), 141.0 (C), 139.3 (C), 139.2 (C), 139.1 (C), 138.9 (C),
138.7 (C), 138.4 (C), 138.3 (C), 138.2 (C), 137.3 (C), 137.20 (C),
137.16 (C), 131.3 (CH), 130.6 (CH), 130.4 (C), 129.5 (CH), 129.4
(CH + CH), 129.2 (CH), 129.1 (CH), 128.90 (CH), 128.87 (CH),
128.86 (CH), 128.69 (CH), 128.67 (CH), 128.5 (CH), 128.30
(CH), 128.25 (CH), 127.9 (CH + CH), 127.8 (CH), 127.58 (CH),
127.56 (CH), 127.4 (CH), 127.33 (CH), 127.30 (CH + CH), 127.1
(CH), 126.8 (CH + CH), 126.7 (CH), 126.0 (CH), 124.9 (CH),
84.4 (C), 84.0 (C), 67.4 (CH), 64.1 (CH), 63.7 (CH), 63.3 (CH),
53.2 (CH3), 51.9 (CH3), 21.3 (CH3), 20.9 (CH3), 20.7 (2  CH3),
20.7 (CH3), 20.4 (CH3), the assignments of the several signals
was confirmed by using gs-HMBC and gs-HMQC measure-
ments. Due to the crowded aromatic region, not all 34 different
aromatic CH signals could be assigned (for the spectra, see
the Supporting Information); IR (neat) 3029 (m), 2950 (m),
1726 (s), 1594 (s), 1576 (s), 1493 (s), 1452 (s), 1225 (s), 1179
(s) cm-1; HRMS (EI, 70 eV) calcd for C33H32N2O2 (M+)
488.2464, found 488.2459.
2-Imidazoline 11. According to General Procedure I, reac-
tion between allylamine (570 mg, 10.0 mmol), isobutyralde-
hyde (720 mg, 10.0 mmol), and 4b (1.0 g, 5.24 mmol), followed
by flash column chromatography, afforded 11 (1.439 g, 91%)
as a brown oil. 1H NMR (250 MHz, CDCl3) ä (ppm) 7.60-7.55
(m, 2H), 7.36-7.12 (m, 7H), 5.97-5.84 (m, 1H), 5.35-5.28 (m,
2H), 3.96 (dd, J ) 15.5, 4.7 Hz, 1H), 3.71 (dd, J ) 15.5, 7.8
Hz, 1H), 3.56 (d, J ) 8.2 Hz, 1H), 0.79 (d, J ) 6.8 Hz, 3H),
0.19 (d, J ) 6.7 Hz, 3H); 13C NMR (63 MHz, CDCl3) ä (ppm)
160.4 (CH), 150.9 (C), 145.7 (C), 140.6 (C), 140.5 (C), 133.3
(CH), 128.3 (2  CH), 127.7 (CH), 127.0 (CH), 126.4 (CH), 124.4
(CH), 119.8 (CH), 119.7 (CH), 119.4 (CH2), 83.6 (C), 73.6 (CH),
51.4 (CH2), 29.9 (CH), 20.7 (CH3), 19.9 (CH3); IR (neat) 2960
(s), 2927 (m), 2869 (m), 1673 (s), 1609 (s), 1449 (s) cm-1; HRMS
(EI, 70 eV) calcd for C21H22N2 (M+) 302.1783, found 302.1779.
2-Imidazoline 14. According to General Procedure I, reac-
tion between 2-aminoethanol (122 mg, 2.0 mmol), p-formal-
dehyde (60 mg, 2.0 mmol), and 4b (191 mg, 1.0 mmol), followed
by flash column chromatography (EtOAc:MeOH:Et3N ) 1:0:
0.01, gradient), afforded 14 (218 mg, 83%) as a sticky yellow
solid. 1H NMR (250 MHz, CDCl3) ä (ppm) 7.58-7.55 (m, 4H),
7.36-7.17 (m, 5H), 3.51 (s, 2H), 3.44-3.40 (m, 2H), 3.36 (br s,
1H), 3.11 (t, J ) 5.4 Hz, 2H); 13C NMR (63 MHz, CDCl3) ä
(ppm) 158.8 (CH), 149.7 (2  C), 139.8 (2  C), 129.1 (2 
CH), 128.5 (2  CH), 124.0 (2  CH), 119.7 (2  CH), 79.2
(C), 59.1 (CH2), 58.6 (CH2), 49.4 (CH2); IR (neat) 3177 (s, br),
3044 (m), 2924 (m), 2854 (m), 1663 (s), 1590 (s), 1449 (s), 1067
(s) cm-1; HRMS (EI, 70 eV) calcd for C17H16N2O (M+) 264.1263,
found 264.1255.
2-Imidazoline 17. According to General Procedure I, reac-
tion between p-methoxybenzylamine (274 mg, 2.0 mmol),
p-hydroxybenzaldehyde (244 mg, 2.0 mmol), and 4b (191 mg,
1.0 mmol), followed by flash column chromatography (EtOAc:
MeOH:Et3N ) 1:0:0.01, gradient), afforded 14 (294 mg, 68%)
as a yellow solid. Precipitation from ethyl acetate gave a white
powder. Mp 245-248 °C; 1H NMR (400 MHz, pyridine-d5) ä
(ppm) 11.28 (br s, 1H), 8.10 (s, 1H), 7.62-7.59 (m, 2H), 7.54
(s, 1H), 7.47 (d, J ) 7.2 Hz, 1H), 7.36-7.29 (m, 4H), 7.17-
7.08 (m, 2H), 7.03 (d, J ) 8.3 Hz, 2H), 6.95 (d, J ) 8.0 Hz,
2H), 6.85 (d, J ) 8.2 Hz, 2H), 5.10 (s, 1H), 4.94 (br s, 1H), 4.76
(d, J ) 14.4 Hz, 1H), 4.14 (d, J ) 14.4 Hz, 1H), 3.68 (s, 3H);
13C NMR (101 MHz, pyridine-d5) ä (ppm) 160.0 (CH), 159.8
(C), 158.2 (C), 151.1 (C), 146.7 (C), 141.6 (C), 140.4 (C), 130.5
(2  CH), 128.8 (2  CH), 128.7 (CH), 128.6 (C), 128.3 (CH),
128.1 (CH), 127.2 (CH), 127.1 (CH), 125.8 (C), 125.0 (CH),
119.91 (CH), 119.86 (CH), 115.8 (2  CH), 114.6 (CH), 85.6
(C), 72.9 (CH), 55.2 (CH3), 49.8 (CH2); IR (KBr) 3438 (s, br),
3035 (s), 2997 (s), 2928 (s), 1609 (s), 1588 (s), 1506 (s), 1249
(s) cm-1; HRMS (EI, 70 eV) calcd for C29H24N2O2 (M+)
432.1838, found 432.1850.
2-Imidazoline 19. According to General Procedure I, reac-
tion between 3-amino-1-propanol (150 mg, 2.0 mmol), 4-hy-
droxybenzaldehyde (244 mg, 2.0 mmol), and 4b (191 mg, 1.0
mmol) in MeOH, followed by flash column chromatography
(EtOAc:Et3N ) 1:0.01, EtOAc:MeOH:Et3N ) 1:0.01:0.01,
gradient) and crystallization from EtOAc and PE, afforded 16
(141 mg, 38%) as a white solid. Mp 190-193 °C; 1H NMR (250
MHz, DMSO-d6) ä (ppm) 9.12 (br s, 1H), 7.66 (s, 1H), 7.64-
7.63 (m, 1H), 7.56-7.49 (m, 2H), 7.40-7.32 (m, 2H), 7.12-
7.06 (m, 1H), 7.01-6.96 (m, 2H), 6.53 (d, J ) 8.5 Hz, 2H), 6.36
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(d, J ) 8.5 Hz, 2H), 4.85 (s, 1H), 4.54 (br s, 1H), 3.50-3.45
(m, 2H), 3.43-3.31 (m, 1H), 3.04-2.94 (m, 1H), 1.74-1.64 (m,
2H); 13C NMR (63 MHz, DMSO-d6) ä (ppm) 159.8 (CH), 156.3
(C), 150.1 (C), 145.6 (C), 140.2 (C), 139.4 (C), 128.3 (CH), 127.8
(3  CH), 127.7 (CH), 126.4 (CH), 126.2 (CH), 125.3 (C), 124.2
(CH), 119.5 (CH), 119.3 (CH), 114.5 (2  CH), 84.2 (C), 72.5
(CH), 58.2 (CH2), 42.3 (CH2), 30.3 (CH2); IR (KBr) 3420 (s, br),
3057 (s), 2933 (s), 1660 (s), 1515 (s), 1447 (s), 1267 (s), 1232
(s), 1047 (s) cm-1; HRMS (EI, 70 eV) calcd for C24H22N2O2 (M+)
370.1681, found 370.1690.
Bis-2-imidazoline 21. According to General Procedure I,
reaction between hexane-1,6-diamine (116 mg, 1.0 mmol),
isobutyraldehyde (144 mg, 2.0 mmol), and 4b (350 mg, 1.83
mmol), followed by flash column chromatography, afforded 21
(370 mg, 67%) as a yellow solid. 1H NMR (250 MHz, CDCl3) ä
(ppm) 7.68 (d, J ) 7.3 Hz, 4H), 7.47-7.23 (m, 14H), 3.73 (d, J
) 7.5 Hz, 2H), 3.43-3.27 (m, 4H), 2.00-1.80 (m, 6H), 1.70-
1.50 (m, 4H), 0.89 (d, J ) 6.8 Hz, 6H), 0.37 (d, J ) 6.8 Hz,
6H); 13C NMR (63 MHz, CDCl3) ä (ppm) 160.2 (2  CH), 151.0
(2  C), 145.8 (2  C), 140.62 (2  C), 140.56 (2  C), 128.3 (4
 CH), 127.7 (2  CH), 127.0 (2  CH), 126.5 (2  CH), 124.5
(2  CH), 119.8 (2  CH), 119.7 (2  CH), 83.4 (2  C), 73.8
(2  CH), 48.3 (2  CH2), 29.6 (2  CH), 27.8 (2  CH2), 27.2
(2  CH2), 20.4 (2  CH3), 20.1 (2  CH3); IR (neat) 2957 (s),
2932 (s), 2868 (m), 1605 (s), 1448 (s) cm-1; HRMS (EI, 70 eV)
calcd for C42H46N4 (M+) 606.3722, found 606.3779.
Bis-2-imidazoline 22. According to General Procedure I,
reaction between isopropylamine (118 mg, 2.0 mmol), isoph-
thalaldehyde (268 mg, 1.0 mmol), and 4b (382 mg, 2.0 mmol),
followed by flash column chromatography, afforded 22 (329
mg, 55%) as a yellow solid. 1H NMR (250 MHz, CDCl3) ä (ppm)
7.59 (s, 1H), 7.48 (s, 1H), 7.47-7.22 (m, 9H), 6.98-6.91 (m,
2H), 6.77-6.11 (m, 9H), 4.76 (s, 2H), 3.20-3.11 (m, 1H), 2.73
(br s, 1H), 1.53 (d, J ) 6.9 Hz, 3H), 1.20 (d, J ) 6.8 Hz, 3H),
1.15 (d, J ) 6.4 Hz, 3H), 0.99 (d, J ) 6.4 Hz, 3H); 13C NMR
(63 MHz, CDCl3) ä (ppm) 156.3 (CH), 156.2 (CH), 150.2 (C),
149.9 (C), 145.1 (2  C), 140.7 (C), 140.4 (C), 140.0 (C), 139.8
(C), 135.74 (C), 135.68 (C), 128.4 (CH), 128.4 (CH), 127.90
(CH), 127.87 (CH), 127.8 (CH), 127.6 (CH), 127.3 (CH), 127.2
(CH), 126.25 (CH), 126.20 (CH), 126.16 (CH), 125.8 (CH), 125.7
(2  CH), 123.9 (CH), 123.8 (CH), 119.5 (CH), 119.4 (CH), 119.3
(CH), 119.0 (CH), 84.2 (C), 84.0 (C), 72.3 (CH), 72.1 (CH), 46.5
(CH), 46.4 (CH), 22.3 (CH3), 22.1 (CH3), 20.3 (CH3), 19.9 (CH3);
IR (neat) 3041 (m), 2968 (s), 1585 (s), 1448 (s), 1225 (s), 1197
(s) cm-1; HRMS (EI, 70 eV) calcd for C42H38N4 (M+) 598.3096,
found 598.3074.
1-(Isocyanomethyl)-4-nitrobenzene (25a). Acetic formic
anhydride (13 mL) was added dropwise to a stirred solution
of 4-nitrobenzylamine (26) (6.7 g, 44.1 mmol) in 90 mL of dry
CH2Cl2 at 0 °C. Stirring was continued for 1 h at room
temperature. Evaporation of the solvent and acids at reduced
pressure yielded 27 as a white solid. 1H NMR (200 MHz,
CDCl3) ä (ppm) 8.26 (s, 1H), 8.13 (d, J ) 9.6 Hz, 2H), 7.41 (d,
J ) 9.6 Hz, 2H), 6.10 (br s, 1H), 4.59 (d, J ) 7.6 Hz, 2H). To
a stirred solution of crude 27 in 150 mL of dry THF at -78 °C
was added Et3N (34 mL, 240 mmol). After this POCl3 (5.6 mL,
54 mmol) in 40 mL of dry THF was added dropwise and the
reaction mixture was allowed to warm to 0 °C. After the
solution was stirred for another 1 h, ice cold water (100 mL)
was added. The mixture was extracted with Et2O (3  80 mL).
Drying with Na2SO4 followed by concentration in vacuo
afforded 25a (7.0 g, 98% over 2 steps) as an almost pure, light
brown solid. Mp 98-101 °C; 1H NMR (250 MHz, CDCl3) ä
(ppm) 8.21 (d, J ) 8.1 Hz, 2H), 7.49 (d, J ) 8.1 Hz, 2H), 4.71
(s, 2H); 13C NMR (63 MHz, CDCl3) ä (ppm) 158.7 (C), 139.0
(C), 126.5 (2  CH), 124.2 (2  CH), 45.8 (C), 44.9 (t, J ) 7.6
Hz, CH2); IR (neat) 2157 (s), 1516 (s), 1351 (s) cm-1; HRMS
(EI, 70 eV) calcd for C8H6N2O2 (M+) 162.0429, found 162.0432.
General Procedure II for the AgOAc-Catalyzed Syn-
thesis of 2-Imidazolines. Reactions were carried out at a
concentration of 1 M of amine, 1 M of aldehyde, and 0.5 M of
isocyanide in dry CH2Cl2, unless stated otherwise. Na2SO4 and
the aldehyde were added, at room temperature, to a stirred
solution of the amine. After the solution was stirred for 2 h,
the isocyanide and AgOAc (2 mol % relative to the isocyanide)
were added and the reaction mixture was stirred at for an
additional 18 h. The reaction mixture was filtered and
concentrated in vacuo. The crude product was purified by flash
column chromatography (PE:EtOAc:Et3N ) 2:1:0.01, gradient).
1,5-Diisopropyl-4-(4-nitrophenyl)-4,5-dihydro-1H-imi-
dazole (28). According to General Procedure II, reaction
between isopropylamine (144 mg, 2.0 mmol), isobutyraldehyde
(118 mg, 2.0 mmol), and 25a (162 mg, 1.0 mmol) gave 28 as a
mixture of diastereomers, together with some 29. The 1H NMR
spectrum of this crude product is shown in the Supporting
Information. When the NMR sample was subjected to air,
oxidation of the syn-diastereomer to imidazole 29 could be
seen. Flash column chromatography afforded anti-28 (106 mg,
39%) as an orange oil and 29 (74 mg, 27%) as a sticky yellow
solid. anti-28: 1H NMR (250 MHz, CDCl3) ä (ppm) 8.12 (d, J
) 8.7 Hz, 2H), 7.31 (d, J ) 8.7 Hz, 2H), 7.16 (d, J ) 1.2 Hz,
1H), 4.76 (d, J ) 6.3 Hz, 1H), 3.40-3.29 (m, 1H), 3.28 (dd, J
) 6.4, 3.8 Hz, 1H), 2.00-1.86 (m, 1H), 1.31 (d, J ) 6.8 Hz,
3H), 1.10 (d, J ) 6.5 Hz, 3H), 0.88 (d, J ) 6.9 Hz, 3H), 0.87 (d,
J ) 6.8 Hz, 3H); 13C NMR (63 MHz, CDCl3) ä (ppm) 153.7
(CH), 152.6 (C), 146.9 (C), 127.5 (2  CH), 123.8 (2  CH),
71.2 (CH), 69.4 (CH), 46.3 (CH), 29.7 (CH), 22.2 (CH3), 22.0
(CH3), 17.8 (CH3), 15.6 (CH3); IR (neat) 2964 (m), 1592 (s), 1519
(s), 1344 (s) cm-1; HRMS (EI, 70 eV) calcd for C15H21N3O2 (M+)
275.1634, found 275.1625.
1,5-Diisopropyl-4-(4-nitrophenyl)-1H-imidazole (29):
1H NMR (400 MHz, CDCl3) ä (ppm) 8.21 (d, J ) 8.8 Hz, 2H),
7.65 (d, J ) 8.8 Hz, 2H), 7.60 (s, 1H), 4.48 (m, 1H), 3.38 (m,
1H), 1.54 (d, J ) 6.8 Hz, 6H), 1.34 (d, J ) 7.3 Hz, 6H); 13C
NMR (101 MHz, CDCl3) ä (ppm) 146.1 (C), 142.9 (C), 135.0
(C), 134.1 (CH), 133.7 (C), 128.9 (2  CH), 123.4 (2  CH),
47.4 (CH), 24.8 (CH), 24.3 (2  CH3), 21.7 (2  CH3); IR (neat)
2971 (m), 2934 (m), 1597 (s), 1515 (s), 1343 (s) cm-1; HRMS
(EI, 70 eV) calcd for C15H19N3O2 (M+) 273.1477, found 273.1478.
1-(4-Methoxybenzyl)-5-(4-methoxyphenyl)-4-(4-nitro-
phenyl)-4,5-dihydro-1H-imidazole (36). According to Gen-
eral Procedure II, reaction between p-methoxybenzylamine
(274 mg, 2.0 mmol), p-anisaldehyde (272 mg, 2.0 mmol), and
25a (162 mg, 1.0 mmol), followed by flash column chromatog-
raphy, afforded 36 (293 mg, 70%) as a 29:71 mixture of
diastereomers as an orange/brown oil. 1H NMR (250 MHz,
CDCl3) ä (ppm) 8.14 (d, J ) 8.6 Hz, 2H), 7.93 (d, J ) 8.6 Hz,
2H), 7.452 (s, 1H), 7.448 (s, 1H), 7.32-6.84 (6H + 10H), 6.76
(d, J ) 8.6 Hz, 2H), 6.63 (d, J ) 8.6 Hz, 2H), 5.53 (d, J ) 11.4
Hz, 1H), 5.06 (d, J ) 10.4 Hz, 1H), 4.77 (d, J ) 11.3 Hz, 1H),
4.48 (d, J ) 14.5 Hz, 1H), 4.38 (d, J ) 14.3 Hz, 1H), 3.99 (d,
J ) 10.2 Hz, 1H), 3.90-3.78 (m, 1H), 3.87 (s, 3H), 3.84 (s, 3H),
3.82 (s, 3H), 3.72 (s, 3H); 13C NMR (101 MHz, CDCl3) ä (ppm)
159.7 (C), 159.32 (C), 159.29 (C), 159.0 (C), 157.9 (CH), 156.7
(CH), 150.6 (C), 147.3 (C), 147.2 (C), 146.5 (C), 131.2 (C), 129.5
(2  CH), 129.4 (2  CH), 129.1 (2  CH), 128.7 (2  CH + 2
 CH), 127.8 (C), 127.4 (2  CH), 126.8 (C), 123.7 (2  CH),
122.6 (2  CH), 114.8 (2  CH), 114.2 (2  CH + 2  CH),
113.6 (2  CH), 79.2 (CH), 74.0 (CH), 71.4 (CH), 66.9 (CH),
55.31 (CH3), 55.28 (CH3), 55.24 (CH3), 55.1 (CH3), 48.8 (CH2),
48.6 (CH2), one quaternary C of the minor diastereomer could
not be detected. Relative stereochemistry was assigned by
using gs-HMBC and gs-NOESY measurements (for spectra,
see the Supporting Information); IR (neat) 1610 (s), 1594 (s),
1513 (s), 1344 (s), 1248 (s) cm-1; HRMS (EI, 70 eV) calcd for
C24H23N3O4 (M+) 417.1689, found 417.1681. After storing the
product for about 6 months under air, only the corresponding
imidazole (a yellow solid) was retrieved. Mp 172-178 °C; 1H
NMR (250 MHz, CDCl3) ä (ppm) 7.97 (d, J ) 9.1 Hz, 2H), 7.58-
7.53 (m, 3H), 7.06 (d, J ) 8.8 Hz, 2H), 6.90-6.82 (m, 4H), 6.74
(d, J ) 8.8 Hz, 2H), 4.80 (s, 2H), 3.80 (s, 3H), 3.71 (s, 3H); 13C
NMR (63 MHz, CDCl3) ä (ppm) 160.4 (C), 159.4 (C), 145.7 (C),
141.4 (C), 137.4 (CH), 136.2 (C), 132.0 (2  CH), 131.2 (C),
128.5 (2  CH), 128.0 (C), 126.3 (2  CH), 123.6 (2  CH),
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121.5 (C), 114.8 (2  CH), 114.2 (2  CH), 55.32 (CH3), 55.27
(CH3), 48.4 (CH2); IR (neat) 1612 (m), 1598 (m), 1513 (s), 1333
(s), 1250 (s), 1176 (m), 1100 (m), 1028 (m) cm-1; HRMS (EI,
70 eV) calcd for C24H21N3O4 (M+) 415.1532, found 415.1518.
1-(4-Methoxybenzyl)-5-isopropyl-4-(4-nitrophenyl)-4,5-
dihydro-1H-imidazole (37). According to General Procedure
II, reaction between p-methoxybenzylamine (274 mg, 2.0
mmol), isobutyraldehyde (118 mg, 2.0 mmol), and 25a (162
mg, 1.0 mmol) gave 37 as a mixture of diastereomers, together
with some of the corresponding imidazole. The 1H NMR
spectrum of this crude product is shown in the Supporting
Information. Flash column chromatography afforded anti-37
(150 mg, 42%) as an orange oil and the corresponding imida-
zole (40 mg, 11%) as a colorless oil. anti-37: 1H NMR (250
MHz, CDCl3) ä (ppm) 8.12 (d, J ) 8.8 Hz, 2H), 7.25 (d, J ) 8.7
Hz, 2H), 7.16-7.13 (m, 3H), 6.89 (d, J ) 8.6 Hz, 2H), 4.86 (d,
J ) 6.8 Hz, 1H), 4.51 (d, J ) 14.9 Hz, 1H), 4.12 (d, J ) 14.9
Hz, 1H), 3.82 (s, 3H), 3.20 (dd, J ) 6.9, 3.8 Hz, 1H), 2.10-
1.93 (m, 1H), 0.98 (d, J ) 6.8 Hz, 3H), 0.92 (d, J ) 6.9 Hz,
3H); 13C NMR (63 MHz, CDCl3) ä (ppm) 159.8 (C), 156.9 (CH),
152.7 (C), 147.3 (C), 129.6 (2  CH), 128.4 (C), 128.1 (2  CH),
124.1 (2  CH), 114.6 (2  CH), 71.1 (CH), 70.8 (CH), 55.7
(CH3), 49.2 (CH2), 29.4 (CH), 18.3 (CH3), 16.6 (CH3); IR (neat)
2959 (m), 1595 (s), 1514 (s), 1345 (s), 1248 (s) cm-1; HRMS
(EI, 70 eV) calcd for C20H23N3O3 (M+) 353.1739, found 353.1749.
Imidazole: 1H NMR (250 MHz, CDCl3) ä (ppm) 8.16 (d, J )
8.9 Hz, 2H), 7.64 (d, J ) 8.9 Hz, 2H), 7.35 (s, 1H), 6.99 (d, J
) 8.8 Hz, 2H), 6.83 (d, J ) 8.8 Hz, 2H), 5.08 (s, 2H), 3.73 (s,
3H), 3.22-3.29 (m, 1H), 1.17 (d, J ) 7.3 Hz, 6H); 13C NMR
(63 MHz, CDCl3) ä (ppm) 159.5 (C), 146.3 (C), 142.9 (C), 137.8
(CH), 136.3 (C), 134.7 (C), 129.0 (2  CH), 128.1 (2  CH),
127.9 (C), 123.4 (2  CH), 114.4 (2  CH), 55.3 (CH3), 49.1
(CH2), 24.7 (CH), 21.7 (2  CH3); IR 2966 (m), 2934 (m), 1598
(m), 1514 (s), 1343 (s), 1249 (s) cm-1; HRMS (EI, 70 eV) calcd
for C20H21N3O3 (M+) 351.1583, found 351.1600.
2-Imidazoline 42. According to General Procedure II,
reaction between benzylamine (214 mg, 2.0 mmol), cyclohex-
anone (196 mg, 2.0 mmol), and 4b (191 mg, 1.0 mmol), followed
by flash column chromatography, afforded 42 (76 mg, 20%)
as a brown oil. 1H NMR (250 MHz, CDCl3) ä (ppm) 7.55-7.49
(m, 2H), 7.42-7.10 (m, 12H), 4.23 (s, 2H), 2.07-1.98 (m, 2H),
1.42-1.30 (m, 2H), 1.10-1.05 (m, 3H), 0.80-0.72 (m, 1H),
0.37-0.26 (m, 2H); 13C NMR (63 MHz, CDCl3) ä (ppm) 159.1
(CH), 147.7 (2  C), 140.6 (2  C), 138.8 (2  C), 128.8 (CH),
128.1 (2  CH), 127.7 (2  CH), 127.6 (CH), 126.6 (2  CH),
126.1 (2  CH), 119.7 (2  CH), 85.2 (C), 69.3 (C), 46.0 (CH2),
32.5 (CH2), 24.9 (2  CH2), 22.7 (2  CH2); IR (neat) 3061 (m),
3030 (m), 2932 (s), 2861 (m), 1675 (m), 1595 (s), 1449 (s) cm-1;
HRMS (EI, 70 eV) calcd for C27H26N2 (M+) 378.2096, found
378.2105.
2-Imidazoline 43. According to General Procedure II,
reaction between benzylamine (214 mg, 2.0 mmol), cyclohex-
anone (196 mg, 2.0 mmol), and 25a (162 mg, 1.0 mmol),
followed by flash column chromatography, afforded 43 (267
mg, 77%) as a brown solid. Mp 130-136 °C; 1H NMR (250
MHz, CDCl3) ä (ppm) 8.09 (d, J ) 8.8 Hz, 2H), 7.38-7.19 (m,
7H), 6.99 (s, 1H), 4.95 (s, 1H), 4.24 (d, J ) 15.2 Hz, 1H), 4.14
(d, J ) 15.2 Hz, 1H), 1.81-0.69 (m, 10H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 156.2 (CH), 147.2 (C), 147.0 (C), 138.3 (C),
129.6 (2  CH), 128.8 (2  CH), 127.7 (CH), 127.6 (2  CH),
123.1 (2  CH), 76.5 (CH), 67.4 (C), 45.6 (CH2), 33.8 (CH2),
30.2 (CH2), 24.9 (CH2), 23.1 (CH2), 21.9 (CH2); IR (neat) 2934
(s), 2855 (m), 1595 (s), 1518 (s), 1345 (s) cm-1; HRMS (EI, 70
eV) calcd for C21H23N3O2 (M+) 349.1790, found 349.1790.
2-Imidazoline 44. According to General Procedure II,
reaction between benzylamine (214 mg, 2.0 mmol), cyclohex-
anone (196 mg, 2.0 mmol), and 4a (185 mg, 1.05 mmol),
followed by flash column chromatography, afforded 44 (212
mg, 55%) as a green/brown oil. 1H NMR (250 MHz, CDCl3) ä
(ppm) 7.87-7.83 (m, 2H), 7.39-7.24 (m, 8H), 7.11 (s, 1H), 4.48
(s, 2H), 3.77 (s, 3H), 2.14-2.06 (m, 1H), 1.82-1.50 (m, 2H),
1.44-1.12 (m, 6H), 0.91-0.89 (m, 1H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 172.5 (C), 156.7 (CH), 138.7 (C), 137.2 (C),
128.8 (2  CH), 128.66 (CH), 128.65 (CH), 127.6 (2  CH),
127.5 (2  CH), 127.2 (2  CH), 85.2 (C), 70.9 (C), 52.3 (CH3),
47.9 (CH2), 31.9 (CH2), 31.4 (CH2), 24.8 (CH2), 22.5 (CH2) 21.8
(CH2); IR (neat) 2926 (s), 1726 (s), 1605 (s), 1452 (s), 1238 (s),
1218 (s) cm-1; HRMS (EI, 70 eV) calcd for C23H26N2O2 (M+)
362.1994, found 362.1996.
2-Imidazoline 45. According to General Procedure II,
reaction between benzylamine (214 mg, 2.0 mmol), acetone
(116 mg, 2.0 mmol), and 4b (191 mg, 1.0 mmol), followed by
flash column chromatography, afforded 45 (244 mg, 72%) as
a white solid. Mp 138-145 °C; 1H NMR (250 MHz, CDCl3) ä
(ppm) 7.65 (d, J ) 7.5 Hz, 2H), 7.54 (d, J ) 7.6 Hz, 2H), 7.45-
7.21 (m, 10H), 4.32 (s, 2H), 1.11 (s, 6H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 158.2 (CH), 147.0 (2  C), 141.2 (2  C), 137.6
(C), 128.6 (2  CH), 128.1 (2  CH), 128.0 (2  CH), 127.5
(CH), 126.5 (2  CH), 125.9 (2  CH), 119.5 (2  CH), 85.4
(C), 68.9 (C), 46.6 (CH2), 22.6 (2  CH3); IR (neat) 3062 (s),
3031 (s), 2969 (s), 2927 (s), 2865 (m), 1674 (s), 1589 (s), 1462
(s), 1449 (s), 1385 (s), 1365 (s), 1263 (s), 1226 (s), 1153 (s) cm-1;
HRMS (EI, 70 eV) calcd for C24H22N2 (M+) 338.1783, found
338.1793.
Methyl 1-Benzyl-5,5-dimethyl-4-phenyl-4,5-dihydro-
1H-imidazole-4-carboxylate (46). According to General
Procedure II, reaction between benzylamine (214 mg, 2.0
mmol), acetone (116 mg, 2.0 mmol), and 4a (175 mg, 1.0 mmol),
followed by flash column chromatography, afforded 46 (201
mg, 62%) as a yellow oil. 1H NMR (250 MHz, CDCl3) ä (ppm)
7.67-7.63 (m, 2H), 7.41-7.26 (m, 8H), 7.17 (s, 1H), 4.22 (s,
2H), 3.78 (s, 3H), 1.42 (s, 3H), 0.86 (s, 3H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 172.0 (C), 156.3 (CH), 138.0 (C), 137.0 (C),
128.7 (2  CH), 127.7 (2  CH), 127.62 (3  CH), 127.60 (CH),
127.5 (2  CH), 84.4 (C), 69.1 (C), 51.9 (CH3), 46.0 (CH2), 22.8
(CH3), 22.2 (CH3); IR (neat) 2924 (m), 1728 (s), 1600 (s), 1263
(s), 1231 (s) cm-1; HRMS (EI, 70 eV) calcd for C20H22N2O2 (M+)
322.1681, found 322.1683.
1-Benzyl-5,5-dimethyl-4-(4-nitrophenyl)-4,5-dihydro-
1H-imidazole (47). According to General Procedure II, reac-
tion between benzylamine (214 mg, 2.0 mmol), acetone (116
mg, 2.0 mmol), and 25a (162 mg, 1.0 mmol), followed by flash
column chromatography, afforded 47 (207 mg, 67%) as a brown
oil. 1H NMR (250 MHz, CDCl3) ä (ppm) 8.23 (d, J ) 8.7 Hz,
2H), 7.50 (d, J ) 8.6 Hz, 2H), 7.45-7.29 (m, 5H), 7.05 (d, J )
1.3 Hz, 1H), 4.95 (s, 1H), 4.31 (d, J ) 15.0 Hz, 1H), 4.21 (d, J
) 15.0 Hz, 1H), 1.42 (s, 3H), 0.67 (s, 3H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 156.4 (CH), 147.4 (C), 147.3 (C), 137.8 (C),
128.8 (2  CH), 128.6 (2  CH), 127.8 (CH), 127.6 (2  CH),
123.3 (2  CH), 79.4 (CH), 66.0 (C), 46.4 (CH2), 27.2 (CH3),
21.0 (CH3); IR (neat) 1593 (s), 1518 (s), 1346 (s) cm-1; HRMS
(EI, 70 eV) calcd for C18H19N3O2 (M+) 309.1477, found 309.1479.
2-Imidazoline 49. According to General Procedure I, reac-
tion between benzylamine (214 mg, 2.0 mmol), 48 (237 mg,
2.0 mmol), and 4b (191 mg, 1.0 mmol), followed by flash
column chromatography, afforded 49 (252 mg, 63%) as a 60:
40 mixture of isomers as a light brown solid. 1H NMR (250
MHz, CDCl3) ä (ppm) 7.59-7.56 (m, 2H + 2H), 7.39-7.13 (m,
12H + 12H), 4.55 (s, 2H), 4.0.43 (s, 2H), 3.14 (d, J ) 5.3 Hz,
2H), 2.80 (d, J ) 6.8 Hz, 2H), 2.35-2.00 (m, 3H + 4H), 1.72-
1.63 (m, 2H), 1.25-1.15 (m, 1H); 13C NMR (63 MHz, CDCl3) ä
(ppm) 157.9 (CH), 157.7 (CH), 146.1 (2  C), 145.6 (2  C),
140.53 (2  C), 140.52 (2  C), 138.0 (C), 137.9 (C), 129.5 (2 
CH), 129.4 (2  CH), 129.03 (2  CH), 128.97 (2  CH), 128.5
(2  CH), 128.3 (CH), 128.2 (CH), 128.1 (2  CH), 127.8 (2 
CH), 127.6 (2  CH), 125.34 (2  CH), 125.28 (2  CH), 120.01
(2  CH), 119.95 (2  CH), 85.8 (C), 84.8 (C), 69.0 (C), 68.2
(C), 48.8 (CH2), 48.7 (CH2), 47.6 (CH2), 46.9 (CH2), 34.4 (2 
CH2), 32.2 (2  CH2), 29.3 (CH), 28.1 (CH); assignment of
relative stereochemistry was achieved by using gs-NOESY
measurements (for spectra, see the Supporting Information);
IR (KBr) 3029, (s), 2948 (s), 2914 (s), 2802 (s), 2749 (s), 2697
(s), 1598 (s), 1451 (s), 737 (s) cm-1; HRMS (EI, 70 eV) calcd
for C26H23ClN2 (M+) 398.1550, found 398.1540.
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2-Imidazoline 50. According to General Procedure I, reac-
tion between benzylamine (214 mg, 2.0 mmol), 48 (237 mg,
2.0 mmol), and 4a (175 mg, 1.0 mmol), followed by flash
column chromatography, afforded 50 (208 mg, 54%) as a 56:
44 mixture of isomers as a yellow/brown oil. 1H NMR (250
MHz, CDCl3) ä (ppm) 7.58-6.82 (m, 11H + 11H), 4.47 (d, J )
2.2 Hz, 2H), 4.43 (s, 2H), 3.67 (s, 3H), 3.65 (s, 3H), 3.35-3.22
(m, 2H), 3.20 (d, J ) 5.4 Hz, 2H), 2.68-2.56 (m, 1H), 2.55-
2.35 (m, 3H + 1H), 2.30-2.19 (1H), 1.96-1.82 (m, 1H + 1H),
1.80-1.68 (m, 1H), 1.49-1.43 (m, 1H); 13C NMR (63 MHz,
CDCl3) ä (ppm) 173.9 (C), 171.6 (C), 156.8 (CH), 156.5 (CH),
138.1 (C), 137.9 (C), 137.8 (C), 137.7 (C), 128.9 (2  CH), 128.8
(2  CH), 128.3 (2  CH), 128.1 (2  CH), 127.9 (4  CH),
127.7 (CH), 127.4 (CH), 127.3 (2  CH), 127.2 (CH), 127.1 (CH),
126.8 (2  CH), 84.8 (C), 84.6 (C), 70.3 (C), 68.7 (C), 52.30
(CH3), 52.27 (CH3), 49.1 (CH2), 49.7 (CH2), 47.1 (CH2), 46.4
(CH2), 34.1 (CH2), 33.9 (CH2), 32.6 (CH2), 31.7 (CH2), 30.7 (CH),
28.2 (CH); assignment of relative stereochemistry was achieved
by using gs-NOESY measurements (for spectra, see the
Supporting Information); IR (neat) 3032 (m), 2954 (m), 2868
(m), 1743 (s), 1672 (s), 1634 (s), 1496 (s), 1455 (s), 1258 (s),
1215 (s), 1175 (s), 699 (s) cm-1; HRMS (EI, 70 eV) calcd for
C22H23ClN2O2 (M+) 382.1397, found 382.1428.
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